You haven't searched anything yet.
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit is seeking an scientist with in vivo physiology experience to contribute to our Metabolism and Immunology programs. Our therapeutic programs are developing reprogramming medicines to restore youthful function in old cells, treating otherwise intractable conditions. In this role, you will design and implement state-of-the-art in vivo models to facilitate the development of these reprogramming medicines, contribute to Discovery and pre-clinical decision making, and serve as a subject matter expert.
As a Scientist on our team, you will:
Full Time
$168k-206k (estimate)
04/10/2024
07/10/2024